| 2XNB: reference: Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents., Wang S, Griffiths G, Midgley CA, Barnett AL, Cooper M, Grabarek J, Ingram L, Jackson W, Kontopidis G, McClue SJ, McInnes C, McLachlan J, Meades C, Mezna M, Stuart I, Thomas MP, Zheleva DI, Lane DP, Jackson RC, Glover DM, Blake DG, Fischer PM, Chem Biol. 2010 Oct 29;17(10):1111-21. PMID: 21035734 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).